Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Share Price

Price 0.30p on 19-03-2026 at 10:30:12
Change 0.00p 0%
Buy 0.31p
Sell 0.29p
Last Trade: Sell 16,714.00 at 0.297p
Day's Volume: 499,272
Last Close: 0.30p
Open: 0.30p
ISIN: GB00BLH13C52
Day's Range 0.30p - 0.30p
52wk Range: 0.225p - 0.80p
Market Capitalisation: £2.23m
VWAP: 0.290234p
Shares in Issue: 742.80m

ValiRx (VAL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 16,714 0.297p Ordinary
09:42:37 - 19-Mar-26
Sell* 482,558 0.29p Ordinary
08:45:42 - 19-Mar-26
Sell* 200,463 0.29p Ordinary
16:07:45 - 18-Mar-26
Buy* 200,130 0.3068p Ordinary
16:04:51 - 18-Mar-26
Sell* 48,176 0.297p Ordinary
14:11:23 - 18-Mar-26
Sell* 1,070,881 0.291p Ordinary
14:05:29 - 18-Mar-26
Sell* 282,300 0.291p Ordinary
13:50:23 - 18-Mar-26
Sell* 1,350 0.3005p Ordinary
11:04:13 - 18-Mar-26
Buy* 3,125 0.32p SI Trade
09:59:33 - 18-Mar-26
Sell* 485,000 0.30p Ordinary
09:57:41 - 18-Mar-26
See more ValiRx trades

ValiRx (VAL) Share Price History

Time period:
to
Date Open High Low Close Volume
19th Mar 2026 (Thu) 0.30 0.30 0.30 0.30 499,272
18th Mar 2026 (Wed) 0.31 0.31 0.30 0.30 2,298,925
17th Mar 2026 (Tue) 0.325 0.325 0.31 0.31 2,517,704
16th Mar 2026 (Mon) 0.335 0.335 0.33 0.33 6,092,829
13th Mar 2026 (Fri) 0.34 0.34 0.335 0.335 3,288,104
12th Mar 2026 (Thu) 0.305 0.35 0.305 0.34 18,423,400
11th Mar 2026 (Wed) 0.305 0.305 0.305 0.305 198,031
10th Mar 2026 (Tue) 0.305 0.305 0.305 0.305 818,183
9th Mar 2026 (Mon) 0.335 0.335 0.305 0.305 11,364,251
6th Mar 2026 (Fri) 0.335 0.335 0.335 0.335 358,148
5th Mar 2026 (Thu) 0.325 0.335 0.325 0.335 3,925,346
4th Mar 2026 (Wed) 0.325 0.325 0.325 0.325 1,168,922
3rd Mar 2026 (Tue) 0.335 0.335 0.315 0.315 4,011,533
2nd Mar 2026 (Mon) 0.335 0.335 0.335 0.335 4,090,766
27th Feb 2026 (Fri) 0.33 0.33 0.33 0.33 2,189,299
26th Feb 2026 (Thu) 0.33 0.33 0.33 0.33 843,666
25th Feb 2026 (Wed) 0.33 0.33 0.33 0.33 6,083,325
24th Feb 2026 (Tue) 0.31 0.33 0.31 0.33 19,390,192
23rd Feb 2026 (Mon) 0.31 0.31 0.31 0.31 5,693,122
20th Feb 2026 (Fri) 0.32 0.32 0.31 0.31 3,871,609
19th Feb 2026 (Thu) 0.32 0.32 0.32 0.32 681,722
See more ValiRx price history

ValiRx (VAL) Regulatory News

Date Source Headline
4th Mar 2026 7:00 am RNS Director/PDMR Shareholding
2nd Mar 2026 7:00 am RNS ValiRx forms ValiRx Animal Health Ltd subsidiary
19th Jan 2026 7:00 am RNS Exercise of Warrants
9th Jan 2026 3:45 pm RNS Replacement: Evaluation and Transfer Agreement
9th Jan 2026 7:00 am RNS New Evaluation and Material Transfer Agreement
8th Jan 2026 1:00 pm RNS Holding(s) in Company
5th Dec 2025 10:56 am RNS Holding(s) in Company
24th Nov 2025 3:54 pm RNS Holding(s) in Company
24th Nov 2025 9:30 am RNS Holding(s) in Company
20th Nov 2025 12:11 pm RNS Result of GM & Issue of Equity
See more ValiRx regulatory news

ValiRx (VAL) Share News

IN BRIEF: ValiRx establishes veterinary oncology-focused subsidiary

3rd Mar 2026 04:05

ValiRx PLC - London-based life science company - Establishes wholly owned subsidiary ValiRx Animal Health Ltd to develop and commercialise its oncology assets in the veterinary market. The subsidiary will use preclinical work from ValiRx human programmes to pursue comparative oncology opportunities. "There is a strong scientific rationale, as well as market opportunities, for this ethical approach and several examples of companies that have followed this route," says Chief Executive Officer Mark Eccleston, who adds that the three key areas of focus will be Osteosarcoma, Lymphoma and Hemangiosarcoma. ValiRx said specialist veterinary venture capitalist funds have been identified and approached with the intention that the subsidiary will be independently funded. The global veterinary oncology market was valued at USD1.58 billion in 2024 and is projected to reach USD4.86 billion by 2034, representing a compound annual growth rate of 12%. Read More

TRADING UPDATES: Life Science REIT portfolio valuation declines 7.8%

9th Jan 2026 19:14

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

TRADING UPDATES: Unilever targets early December Ice Cream spin-off

4th Nov 2025 20:07

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: Getech hails contracts; Rome Resources plunges

30th Oct 2025 11:18

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

LONDON MARKET OPEN: Stocks fall after Fed casts doubt on December cut

30th Oct 2025 09:16

(Alliance News) - Stock prices in London opened lower on Thursday, as the FTSE 100 retreated from a record high in the wake of a "hawkish" cut by the Federal Reserve. Read More

See more ValiRx news
FTSE 100 Latest
Value10,105.40
Change-199.89

Login to your account

Forgot Password?

Not Registered